✦ LIBER ✦

Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation in Relation to the CHADS2 Score: A Subgroup Analysis of the J-ROCKET AF Trial

✍ Scribed by Hori, Masatsugu; Matsumoto, Masayasu; Tanahashi, Norio; Momomura, Shin-ichi; Uchiyama, Shinichiro; Goto, Shinya; Izumi, Tohru; Koretsune, Yukihiro; Kajikawa, Mariko; Kato, Masaharu; Ueda, Hitoshi; Iekushi, Kazuma; Yamanaka, Satoshi; Tajiri, Masahiro

Book ID: 121908869
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 245 KB
Volume: 23
Category: Article
ISSN: 1532-8511
DOI: 10.1016/j.jstrokecerebrovasdis.2013.07.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Net Clinical Benefit of Rivaroxaban vers

Net Clinical Benefit of Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation: A Subgroup Analysis of J-ROCKET AF

✍ Uchiyama, Shinichiro; Hori, Masatsugu; Matsumoto, Masayasu; Tanahashi, Norio; Mo 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 403 KB

Rivaroxaban versus warfarin in Japanese

Rivaroxaban versus warfarin in Japanese patients with non-valvular atrial fibrillation in relation to hypertension: a subgroup analysis of the J-ROCKET AF trial

✍ Matsumoto, Masayasu; Hori, Masatsugu; Tanahashi, Norio; Momomura, Shin-ichi; Uch 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 302 KB

Rivaroxaban compared with warfarin in pa

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF

✍ Graeme J Hankey; Manesh R Patel; Susanna R Stevens; Richard C Becker; Günter Bre 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 252 KB

USE OF THE CHADS2 AND CHA2DS2-VASC SCORE

USE OF THE CHADS2 AND CHA2DS2-VASC SCORE IN JAPANESE PATIENTS WITH ATRIAL FIBRILLATION: A SUB-ANALYSIS OF THE JAPAN THROMBOSIS REGISTRY FOR ATRIAL FIBRILLATION, CORONARY OR CEREBROVASCULAR EVENTS (J-TRACE)

✍ Eri Toda; Gregory YH Lip; Shinichiro Uchiyama; Kazyuyuki Shimada; Hideki Origasa 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Apixaban compared with warfarin in patie

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

✍ J Donald Easton; Renato D Lopes; M Cecilia Bahit; Daniel M Wojdyla; Christopher 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 264 KB

Letter by Apostolakis et al Regarding Ar

Letter by Apostolakis et al Regarding Article, “Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R 2 CHADS 2 Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study Cohorts”

✍ Apostolakis, Stavros ;Lane, Deirdre A. ;Banerjee, Amitava 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 419 KB